Tele-Prescribing Flexibilities Extended Just Ahead of PHE Expiration
Two days before a proposed rule change by the Drug Enforcement Administration (DEA) regulating the prescribing of controlled substances via telemedicine was set to take effect, the agency issued a temporary rule to extend COVID-era telehealth prescribing flexibilities for another six months, through November 11, 2023. Apparently, the DEA was listening. The agency received some […]
Read More… from Tele-Prescribing Flexibilities Extended Just Ahead of PHE Expiration